AGN : Summary for Allergan plc Ordinary Shares - Yahoo Finance

U.S. Markets open in 6 hrs 28 mins

Allergan plc (AGN)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
235.29+1.30 (+0.56%)
At close: 4:01PM EDT
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close233.99
Bid0.00 x
Ask0.00 x
Day's Range233.00 - 237.20
52 Week Range184.50 - 279.98
Avg. Volume3,615,605
Market Cap78.88B
PE Ratio (TTM)6.16
Earnings DateN/A
Dividend & Yield2.80 (1.20%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters2 hours ago

    After Trump rally, equity investors move into healthcare, retailers

    High U.S. share prices are pushing Lipper Award-winning equity fund managers into the shares of beaten-down healthcare companies, retailers and emerging-market stocks that they say offer a greater chance for outsized gains. Fund managers from Poplar Forest, Parnassus Investments and Brandes Investment Partners are among the 2017 Lipper Award winners who are concerned about the high valuation of the benchmark S&P 500 index. With a forward price-to-earnings ratio above 18, the index is at the high end of its historical range.

  • The Most Attractive Value Stock There Is?
    GuruFocus.com9 hours ago

    The Most Attractive Value Stock There Is?

    These value investors love Allergan

  • Investopedia16 hours ago

    Insys Therapeutics' Syndros Gets Final DEA Rule

    The DEA has approved Syndros, an oral drug for chemotherapy and AIDs patients, as a Schedule II drug.